HEADER    METAL BINDING PROTEIN                   08-JAN-06   2FMA              
TITLE     STRUCTURE OF THE ALZHEIMER'S AMYLOID PRECURSOR PROTEIN (APP) COPPER   
TITLE    2 BINDING DOMAIN IN 'SMALL UNIT CELL' FORM, ATOMIC RESOLUTION          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: AMYLOID BETA A4 PROTEIN PRECURSOR;                         
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: COPPER BINDING DOMAIN(RESIDUES 133-189);                   
COMPND   5 SYNONYM: AMYLOID PRECURSOR PROTEIN, AMYLOID BETA A4 PROTEIN, SOLUBLE 
COMPND   6 APP-ALPHA, SOLUBLE APP-BETA;                                         
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: PICHIA PASTORIS;                                  
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 4922;                                       
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: GS115;                                     
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PPIC-9                                    
KEYWDS    ALPHA-BETA TWO-LAYERED SANDWICH, METAL BINDING PROTEIN                
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    G.K.-W.KONG                                                           
REVDAT   4   13-JUL-11 2FMA    1       VERSN                                    
REVDAT   3   26-JAN-10 2FMA    1       JRNL                                     
REVDAT   2   24-FEB-09 2FMA    1       VERSN                                    
REVDAT   1   16-JAN-07 2FMA    0                                                
JRNL        AUTH   G.K.KONG,J.J.ADAMS,R.CAPPAI,M.W.PARKER                       
JRNL        TITL   STRUCTURE OF ALZHEIMER'S DISEASE AMYLOID PRECURSOR PROTEIN   
JRNL        TITL 2 COPPER-BINDING DOMAIN AT ATOMIC RESOLUTION.                  
JRNL        REF    ACTA CRYSTALLOGR.,SECT.F      V.  63   819 2007              
JRNL        REFN                   ESSN 1744-3091                               
JRNL        PMID   17909280                                                     
JRNL        DOI    10.1107/S1744309107041139                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    0.85 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 0.85                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 13.85                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 86.0                           
REMARK   3   CROSS-VALIDATION METHOD           : FREE R                         
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.131                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.131                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.150                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 2107                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 41418                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : 0.124                  
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : 31537                  
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 475                                           
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 6                                             
REMARK   3   SOLVENT ATOMS      : 115                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : 596.00                  
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : 449.00                  
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : 2                       
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : 5469                    
REMARK   3   NUMBER OF RESTRAINTS                     : 5492                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.026                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.036                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000                   
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : 0.031                   
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : 0.105                   
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : 0.105                   
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : 0.113                   
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : 0.006                   
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : 0.027                   
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : 0.094                   
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER                        
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2FMA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JAN-06.                  
REMARK 100 THE RCSB ID CODE IS RCSB036047.                                      
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 20-JUL-04                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 8.0                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 14-BM-C                            
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9                                
REMARK 200  MONOCHROMATOR                  : BENT GE(111) MONOCHROMATOR         
REMARK 200  OPTICS                         : BENT CONICAL SI-MIRROR (RH         
REMARK 200                                   COATED)                            
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 4                     
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 41418                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 0.850                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 20.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 1.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 90.5                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.85                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 0.87                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 43.8                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 1.50                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : 0.37000                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 1.700                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: RIGID BODY REFINEMENT        
REMARK 200 SOFTWARE USED: SHELX                                                 
REMARK 200 STARTING MODEL: PDB ENTRY 2FJZ                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 33.80                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 8.0, 28-32% (W/V) PEG      
REMARK 280  10000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       15.64450            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       25.04400            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       16.24400            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       25.04400            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       15.64450            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       16.24400            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS                                      
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)               
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION                     
REMARK 500    LYS A 155   CD    LYS A 155   CE     -0.177                       
REMARK 500    GLU A 160   CD    GLU A 160   OE2    -0.073                       
REMARK 500    GLY A 175   N     GLY A 175   CA     -0.093                       
REMARK 500    LEU A 189   C     LEU A 189   OXT     0.230                       
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A 177       18.52   -152.99                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A2047        DISTANCE =  5.12 ANGSTROMS                       
REMARK 525    HOH A2087        DISTANCE =  6.71 ANGSTROMS                       
REMARK 525    HOH A2093        DISTANCE =  6.61 ANGSTROMS                       
REMARK 525    HOH A2106        DISTANCE =  5.51 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1001                
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1OWT   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2FJZ   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2FK1   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2FK2   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2FK3   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 2FKL   RELATED DB: PDB                                   
DBREF  2FMA A  133   189  UNP    P05067   A4_HUMAN       133    189             
SEQADV 2FMA GLU A  131  UNP  P05067              CLONING ARTIFACT               
SEQADV 2FMA ALA A  132  UNP  P05067              CLONING ARTIFACT               
SEQRES   1 A   59  GLU ALA CYS LYS PHE LEU HIS GLN GLU ARG MET ASP VAL          
SEQRES   2 A   59  CYS GLU THR HIS LEU HIS TRP HIS THR VAL ALA LYS GLU          
SEQRES   3 A   59  THR CYS SER GLU LYS SER THR ASN LEU HIS ASP TYR GLY          
SEQRES   4 A   59  MET LEU LEU PRO CYS GLY ILE ASP LYS PHE ARG GLY VAL          
SEQRES   5 A   59  GLU PHE VAL CYS CYS PRO LEU                                  
HET    GOL  A1001       6                                                       
HETNAM     GOL GLYCEROL                                                         
HETSYN     GOL GLYCERIN; PROPANE-1,2,3-TRIOL                                    
FORMUL   2  GOL    C3 H8 O3                                                     
FORMUL   3  HOH   *115(H2 O)                                                    
HELIX    1   1 THR A  146  LYS A  161  1                                  16    
SHEET    1   A 3 LYS A 134  GLU A 139  0                                        
SHEET    2   A 3 LYS A 178  PRO A 188 -1  O  VAL A 182   N  GLN A 138           
SHEET    3   A 3 THR A 163  CYS A 174 -1  N  HIS A 166   O  VAL A 185           
SSBOND   1 CYS A  133    CYS A  187                          1555   1555  2.07  
SSBOND   2 CYS A  144    CYS A  174                          1555   1555  2.03  
SSBOND   3 CYS A  158    CYS A  186                          1555   1555  2.03  
SITE     1 AC1  9 ALA A 132  HIS A 147  GLY A 169  GLU A 183                    
SITE     2 AC1  9 VAL A 185  HOH A2005  HOH A2010  HOH A2085                    
SITE     3 AC1  9 HOH A2088                                                     
CRYST1   31.289   32.488   50.088  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.031960  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.030781  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.019965        0.00000                         
ATOM      2  CA  GLU A 131       6.535  -3.095  12.537  1.00 25.26           C  
ANISOU    2  CA  GLU A 131     3807   1857   3934  -1405  -2068   1228       C  
ATOM     11  CA  ALA A 132       9.081  -0.663  13.939  1.00 12.12           C  
ANISOU   11  CA  ALA A 132     2216   1012   1376   -447   -227    321       C  
ATOM     16  CA  CYS A 133       9.968   2.835  12.830  1.00  8.15           C  
ANISOU   16  CA  CYS A 133     1146    931   1017   -116    -58    199       C  
ATOM     22  CA  LYS A 134      12.044   3.323   9.698  1.00  7.89           C  
ANISOU   22  CA  LYS A 134     1158    794   1045     11     88     15       C  
ATOM     31  CA  PHE A 135      15.009   5.714   9.417  1.00  7.44           C  
ANISOU   31  CA  PHE A 135     1122    748    959     26     59     56       C  
ATOM     42  CA  LEU A 136      15.414   7.355   6.003  1.00  8.36           C  
ANISOU   42  CA  LEU A 136     1470    789    915    -33    100     24       C  
ATOM     50  CA  HIS A 137      17.874   9.767   4.347  1.00 10.15           C  
ANISOU   50  CA  HIS A 137     1780    910   1167   -136    453     25       C  
ATOM     60  CA  GLN A 138      16.876  12.008   1.431  1.00  8.86           C  
ANISOU   60  CA  GLN A 138     1488    824   1055   -111    270   -112       C  
ATOM     69  CA  GLU A 139      19.060  14.676  -0.140  1.00  8.11           C  
ANISOU   69  CA  GLU A 139     1252    787   1044    -30     72     -2       C  
ATOM     78  CA  ARG A 140      19.346  16.446  -3.425  1.00  9.23           C  
ANISOU   78  CA  ARG A 140     1230   1411    868   -221    142    -78       C  
ATOM     89  CA  MET A 141      22.156  17.925  -5.464  1.00  7.99           C  
ANISOU   89  CA  MET A 141     1053    979   1002    -99     98    -60       C  
ATOM     97  CA  ASP A 142      20.248  20.370  -7.723  1.00  8.84           C  
ANISOU   97  CA  ASP A 142     1322   1019   1017     37    123     91       C  
ATOM    105  CA  VAL A 143      18.858  22.924  -5.259  1.00  8.90           C  
ANISOU  105  CA  VAL A 143     1018   1179   1186     99   -139   -208       C  
ATOM    112  CA  CYS A 144      19.105  24.133  -1.688  1.00  7.92           C  
ANISOU  112  CA  CYS A 144     1080   1038    892    139     64     73       C  
ATOM    118  CA  GLU A 145      15.842  24.422   0.262  1.00  7.96           C  
ANISOU  118  CA  GLU A 145      977    977   1068     71     62   -113       C  
ATOM    127  CA  THR A 146      14.460  25.667   3.521  1.00  7.39           C  
ANISOU  127  CA  THR A 146      947    944    915     51     13    -36       C  
ATOM    134  CA  HIS A 147      13.552  23.817   6.701  1.00  7.26           C  
ANISOU  134  CA  HIS A 147      979    866    913     27    -64    -20       C  
ATOM    144  CA  LEU A 148       9.868  24.071   5.745  1.00  7.07           C  
ANISOU  144  CA  LEU A 148      912    824    948     10      7    -61       C  
ATOM    152  CA  HIS A 149      10.499  22.282   2.444  1.00  7.16           C  
ANISOU  152  CA  HIS A 149      977    853    892    -17    -93    -29       C  
ATOM    162  CA  TRP A 150      12.459  19.491   4.087  1.00  7.16           C  
ANISOU  162  CA  TRP A 150      923    723   1075      8    -53    -66       C  
ATOM    176  CA  HIS A 151       9.910  19.048   6.864  1.00  7.77           C  
ANISOU  176  CA  HIS A 151     1189    740   1021    -44     66    -16       C  
ATOM    186  CA  THR A 152       7.247  18.779   4.189  1.00  7.91           C  
ANISOU  186  CA  THR A 152      962    790   1252    -18    -72    -26       C  
ATOM    193  CA  VAL A 153       9.279  16.179   2.288  1.00  7.76           C  
ANISOU  193  CA  VAL A 153     1217    835    897    -20    -48    -36       C  
ATOM    200  CA  ALA A 154       9.808  14.087   5.420  1.00  7.73           C  
ANISOU  200  CA  ALA A 154     1113    740   1082     -2   -123     79       C  
ATOM    205  CA  LYS A 155       6.151  14.232   6.447  1.00  8.02           C  
ANISOU  205  CA  LYS A 155     1105    844   1100    -55    -87    -63       C  
ATOM    214  CA  GLU A 156       4.878  13.380   2.982  1.00  8.50           C  
ANISOU  214  CA  GLU A 156     1172    814   1243     -4   -279      3       C  
ATOM    223  CA  THR A 157       7.381  10.572   2.485  1.00  8.50           C  
ANISOU  223  CA  THR A 157     1253    879   1099    -54   -149    -48       C  
ATOM    230  CA  CYS A 158       6.354   8.940   5.728  1.00  7.82           C  
ANISOU  230  CA  CYS A 158     1151    837    982     18   -154   -119       C  
ATOM    236  CA  SER A 159       2.712   9.270   4.750  1.00  9.36           C  
ANISOU  236  CA  SER A 159     1217    894   1447    -67   -213     -7       C  
ATOM    242  CA  GLU A 160       3.430   7.635   1.324  1.00 10.16           C  
ANISOU  242  CA  GLU A 160     1706    817   1336    -39   -635    -93       C  
ATOM    251  CA  LYS A 161       4.840   4.680   3.282  1.00  8.80           C  
ANISOU  251  CA  LYS A 161     1426    837   1081    -34   -234    -32       C  
ATOM    260  CA  SER A 162       1.813   4.334   5.493  1.00  9.49           C  
ANISOU  260  CA  SER A 162     1216   1045   1346    -79   -120   -190       C  
ATOM    266  CA  THR A 163       3.521   5.871   8.580  1.00  8.83           C  
ANISOU  266  CA  THR A 163     1258    931   1167   -178    -14    -29       C  
ATOM    273  CA  ASN A 164       3.713   9.171  10.445  1.00  9.04           C  
ANISOU  273  CA  ASN A 164     1194    928   1314   -106    168    -90       C  
ATOM    281  CA  LEU A 165       6.813  11.316  10.819  1.00  8.42           C  
ANISOU  281  CA  LEU A 165     1189    857   1154      6    105    -15       C  
ATOM    289  CA  HIS A 166       8.121  11.417  14.327  1.00  8.93           C  
ANISOU  289  CA  HIS A 166     1426    977    990    -35    160     -9       C  
ATOM    299  CA  ASP A 167      11.343  13.270  14.095  1.00 11.05           C  
ANISOU  299  CA  ASP A 167     1811   1373   1014   -528    255   -122       C  
ATOM    307  CA  TYR A 168      13.801  14.648  11.565  1.00  9.41           C  
ANISOU  307  CA  TYR A 168     1506   1004   1064   -370    382   -271       C  
ATOM    319  CA  GLY A 169      16.990  16.594  11.126  1.00  9.48           C  
ANISOU  319  CA  GLY A 169     1502   1288    810   -523     27     51       C  
ATOM    324  CA AMET A 170      18.223  18.595   8.130  0.60  7.41           C  
ANISOU  324  CA AMET A 170     1130    802    882    -58    165    114       C  
ATOM    325  CA BMET A 170      18.256  18.712   8.336  0.40  6.90           C  
ANISOU  325  CA BMET A 170      828    964    830     28    -28    160       C  
ATOM    339  CA  LEU A 171      21.411  17.794   6.271  1.00  7.92           C  
ANISOU  339  CA  LEU A 171      987    978   1045     54     93    111       C  
ATOM    347  CA  LEU A 172      24.100  19.711   4.446  1.00  7.96           C  
ANISOU  347  CA  LEU A 172     1034    963   1027    -19    113     13       C  
ATOM    355  CA  PRO A 173      23.410  23.347   5.352  1.00  7.92           C  
ANISOU  355  CA  PRO A 173     1033   1005    973     13     17     26       C  
ATOM    362  CA  CYS A 174      23.636  25.635   2.319  1.00  8.27           C  
ANISOU  362  CA  CYS A 174     1240    863   1040     -5    155     30       C  
ATOM    368  CA  GLY A 175      23.597  29.355   1.794  1.00 10.37           C  
ANISOU  368  CA  GLY A 175     1742    915   1283   -202    344     41       C  
ATOM    372  CA  ILE A 176      22.595  31.478   4.749  1.00 11.91           C  
ANISOU  372  CA  ILE A 176     1951   1203   1371     38    -89   -377       C  
ATOM    380  CA  ASP A 177      19.330  29.559   5.639  1.00 11.27           C  
ANISOU  380  CA  ASP A 177     2344    864   1074    212    289    -80       C  
ATOM    388  CA  LYS A 178      18.942  26.455   3.468  1.00  7.46           C  
ANISOU  388  CA  LYS A 178     1056    798    980     25    114     16       C  
ATOM    397  CA  PHE A 179      19.833  22.770   3.407  1.00  6.81           C  
ANISOU  397  CA  PHE A 179      929    803    855    -61     69     24       C  
ATOM    408  CA  ARG A 180      20.301  19.933   0.897  1.00  6.89           C  
ANISOU  408  CA  ARG A 180     1025    805    789    -45      7    -44       C  
ATOM    419  CA  GLY A 181      18.525  17.101   2.653  1.00  7.47           C  
ANISOU  419  CA  GLY A 181     1255    733    849    -99     80    -32       C  
ATOM    423  CA  VAL A 182      16.783  15.541   5.629  1.00  7.01           C  
ANISOU  423  CA  VAL A 182     1082    769    811    -17     10    -23       C  
ATOM    431  CA AGLU A 183      17.088  12.352   7.586  0.55  7.27           C  
ANISOU  431  CA AGLU A 183     1104    645   1012     32    220     15       C  
ATOM    432  CA BGLU A 183      17.236  12.464   7.930  0.45  7.18           C  
ANISOU  432  CA BGLU A 183     1053    807    868    -40    112     20       C  
ATOM    448  CA  PHE A 184      13.981  11.279   9.432  1.00  7.14           C  
ANISOU  448  CA  PHE A 184     1040    771    903    -60    108     19       C  
ATOM    459  CA  VAL A 185      12.159   8.582  11.338  1.00  7.20           C  
ANISOU  459  CA  VAL A 185     1002    894    839    -55     10     80       C  
ATOM    466  CA  CYS A 186       8.759   7.322  10.219  1.00  7.65           C  
ANISOU  466  CA  CYS A 186      987    940    980    -33    -46    111       C  
ATOM    472  CA  CYS A 187       6.708   5.355  12.779  1.00  8.27           C  
ANISOU  472  CA  CYS A 187     1112   1024   1007    -87     62    144       C  
ATOM    478  CA  PRO A 188       3.649   3.124  12.555  1.00 10.90           C  
ANISOU  478  CA  PRO A 188     1487   1280   1376   -480     92    -19       C  
ATOM    485  CA  LEU A 189       0.278   4.652  12.301  1.00 19.40           C  
ANISOU  485  CA  LEU A 189     1282   2749   3341   -545    198      9       C  
TER     486      LEU A 189                                                      
END                                                                             
